Why Patients Switch GLP-1 Medications to Wegovy
Complete Wegovy Doses Guide for Medication Switchers
Switching between GLP-1 medications requires understanding Wegovy's specific dose escalation protocol. The five doses of Wegovy follow a structured 16-week progression: 0.25mg (weeks 1-4), 0.5mg (weeks 5-8), 1mg (weeks 9-12), 1.7mg (weeks 13-16), and 2.4mg maintenance dose from week 17 onwards. Unlike some other GLP-1 medications, you cannot skip Wegovy doses during escalation - each step is clinically necessary to minimise side effects and optimise tolerance. When switching from Mounjaro or other semaglutide medications, your prescriber will determine the appropriate starting dose of Wegovy based your current medication and tolerance level.
The key advantage of switching to Wegovy doses lies in the medication's robust clinical evidence and UK licensing specifically for weight management. Wegovy (semaglutide) is manufactured by Novo Nordisk and differs from Ozempic, which is licensed only for type 2 diabetes treatment. Understanding these doses of Wegovy ensures you receive the correct prescription-only medicine for your weight management goals. Our GPhC-registered pharmacy (#9012878) provides comprehensive support throughout your switching process, ensuring continuity of care and proper dose progression.
Wegovy Doses Pricing: Switch & Save Breakdown
Cost savings represent a primary reason patients switch to doses of Wegovy through EverydayMeds. Our single pen prices start with the 0.25mg starter dose at £79.99, progressing to 0.5mg at £94.99, 1mg at £99.99, 1.7mg at £139.99, and the 2.4mg maintenance dose at £209.99. New customers apply discount code FIRST40 at checkout, while returning patients use code DOSE25 to access these competitive prices. These Wegovy doses often cost significantly less than equivalent Mounjaro prescriptions, particularly at higher maintenance doses. Bundle options provide additional convenience for planned dose escalation, such as our Progress Duo (0.5mg & 1mg) for £189.99 or the complete Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99.
The financial advantage of switching to doses of Wegovy becomes particularly evident during long-term treatment. Monthly costs decrease substantially compared to many alternative GLP-1 medications, especially when using our discount codes consistently. Bundle pricing eliminates multiple ordering processes and ensures continuous supply during your dose escalation phases. Our transparent pricing structure means no hidden costs or unexpected charges - the advertised doses of Wegovy prices represent your final payment after discount code application at checkout.
Clinical Evidence Supporting Wegovy Doses Effectiveness
The doses of Wegovy demonstrate remarkable efficacy in clinical trials, particularly the landmark STEP programme. In the STEP 1 trial, participants taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP 2 trial showed Wegovy doses produced around clinically studied weight loss in patients with type 2 diabetes, while STEP 3 demonstrated approximately clinically studied weight loss when combined with intensive behavioural therapy.
Long-term data from STEP 5 revealed that doses of Wegovy sustained approximately clinically studied weight loss at two years, confirming the medication's durability. The recent SELECT cardiovascular outcomes trial showed Wegovy reduced major cardiovascular events by 20% (HR 0.80), highlighting benefits beyond weight management. These clinical results support why many patients switch to doses of Wegovy from other GLP-1 medications - the evidence base specifically supports its use as a prescription-only medicine for weight management in adults with BMI ≥30 or BMI ≥27 with comorbidities.
Understanding How Wegovy Doses Work in Your Body
Wegovy doses contain semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones. This mechanism works by binding to GLP-1 receptors in your brain's appetite control centres, reducing hunger signals and promoting satiety after smaller meals. The progressive doses of Wegovy allow your body to gradually adapt to increased semaglutide levels, minimising gastrointestinal side effects while optimising appetite suppression. Each weekly injection maintains consistent drug levels, unlike daily medications that create peaks and troughs. The 2.4mg maintenance dose represents the therapeutically optimal level for sustained weight management, established through extensive clinical trials. This biological approach explains why doses of Wegovy must be taken alongside a reduced-calorie diet and increased physical activity - the medication enhances your natural satiety signals rather than replacing healthy lifestyle changes.
EverydayMeds Wegovy Ordering Process Explained
Switching to doses of Wegovy through EverydayMeds begins with our streamlined 3-minute online clinical assessment, designed to evaluate your suitability for this prescription-only medicine. Our qualified prescribers review your medical history, current medications, and weight management goals within standard 3 working days (or 24 hours with express service). Once approved, your chosen doses of Wegovy ship via next-day delivery in temperature-controlled packaging, ensuring medication integrity from our GPhC-registered pharmacy (#9012878). The cold-chain delivery system maintains the required 2-8°C storage temperature throughout transit. Our pharmacy team coordinates timing to prevent treatment gaps when switching from other GLP-1 medications, providing seamless continuity of care. All Wegovy doses arrive with comprehensive patient information leaflets and injection guidance materials.
Storage and Practical Management of Wegovy Doses
Proper storage of Wegovy doses ensures medication effectiveness and safety throughout your treatment. Unopened pens must remain refrigerated at 2-8°C until first use, but offer superior travel convenience compared to some alternatives - Wegovy doses can survive 6 weeks at room temperature below 30°C once removed from the fridge, versus Mounjaro's 21-day limit. Each pen contains 4 doses using Novo Nordisk's FlexTouch injection system, which provides consistent, accurate dosing with minimal injection pain. The dose escalation schedule requires careful planning - you cannot accelerate or skip doses of Wegovy, so ordering your next strength in advance prevents treatment interruptions. After opening, each pen remains usable for 6 weeks when stored properly, though most patients complete the 4 weekly doses well within this timeframe. The pre-filled pen design eliminates mixing or preparation requirements, making doses of Wegovy straightforward to self-administer weekly.
Wegovy Dose Conversion Guide for Medication Switchers
Converting from other GLP-1 medications to doses of Wegovy requires clinical oversight, as direct dose equivalencies don't exist between different drug formulations. Patients switching from Mounjaro (tirzepatide) typically restart Wegovy at the 0.25mg dose regardless of their previous Mounjaro strength, allowing proper tolerance assessment with semaglutide. Those transitioning from Ozempic may continue at equivalent semaglutide doses, though Wegovy's weight management licensing provides proper therapeutic indication. Your EverydayMeds prescriber evaluates your current treatment response, side effect profile, and clinical goals to determine optimal starting doses of Wegovy.
The switch timing requires coordination to maintain therapeutic continuity while avoiding medication overlap. Most prescribers recommend completing your current GLP-1 medication supply before starting doses of Wegovy, typically resulting in a 1-week treatment gap. This brief interval rarely compromises treatment effectiveness and allows clear assessment of Wegovy-specific effects. Our pharmacy stocks both medications, enabling flexible switching timing based on your prescriber's recommendations and your personal schedule preferences.
Complete Your Switch to Wegovy Doses Today
Ready to switch and save with doses of Wegovy from EverydayMeds? Our streamlined process eliminates switching barriers while maximising cost savings through competitive pricing and discount codes. New customers use code FIRST40 at checkout, while returning patients apply DOSE25 for continued savings on all doses of Wegovy. Our GPhC-registered pharmacy service (#9012878) ensures professional oversight throughout your medication transition, with qualified prescribers available for clinical guidance. Visit our weight loss collection at https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and discover why thousands of patients choose EverydayMeds for their weight management medications. Take advantage of next-day delivery and seamless switching support - your new doses of Wegovy await.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
